What nursing considerations should be taken into account when administering amantadine?

Nursing Considerations for Amantadine

Nurses must prioritize careful dose adjustment based on renal function and age, monitor for CNS and anticholinergic effects, and never abruptly discontinue amantadine due to risk of severe withdrawal complications including Neuroleptic Malignant Syndrome.

Critical Safety Monitoring

Abrupt Discontinuation Risk

• Never stop amantadine suddenly - this can precipitate life-threatening complications including delirium, agitation, hallucinations, paranoid reactions, stupor, anxiety, depression, and Neuroleptic Malignant Syndrome (NMS) 1
• NMS presents with fever, muscle rigidity, altered consciousness, autonomic dysfunction, elevated CPK, and can be fatal 1
• When discontinuation is necessary, taper gradually under physician supervision

Renal Function-Based Dosing

This is the most critical nursing consideration - amantadine accumulates dangerously when renal function declines 1:

• Elderly patients (≥65 years): Maximum dose 100 mg/day (not 200 mg) due to age-related renal decline 2, 1
• Creatinine clearance <50 mL/min: Requires dose reduction per package insert guidelines 2
• Creatinine clearance <10 mL/min: Reduce to 100 mg/day 2
• Monitor serum creatinine regularly - elderly nursing home residents showed toxic concentrations (up to 5,810 ng/mL) with standard dosing 3
• 78% of elderly patients qualified for further dose reduction based on estimated creatinine clearance 3

High-Risk Populations Requiring Enhanced Monitoring

Contraindications and Special Precautions

Amantadine should not be administered to 4:

• Pregnant women (Category C - teratogenic in animals, excreted in breast milk) 1
• Elderly patients with impaired renal function without dose adjustment
• Patients with neuropsychiatric disorders or seizure history
• Patients receiving other neuropsychiatric medications
• Nursing mothers (drug excreted in human milk) 1

Patients at Highest Risk for Adverse Events

Monitor intensively in patients with 1, 5:

• Congestive heart failure, peripheral edema, or orthostatic hypotension
• Liver disease (rare reversible enzyme elevations reported)
• History of recurrent eczematoid rash
• Psychosis or severe psychoneurosis
• Female gender (94% of adverse events occurred in women in one study) 6

Adverse Effect Monitoring

Central Nervous System Effects (Most Common)

Watch for and document 1, 5:

• Dizziness, lightheadedness, confusion
• Hallucinations (most common adverse event in clinical trials) 7
• Insomnia, hyperexcitability, agitation
• Tremors, ataxia, slurred speech
• Mood disturbances, psychosis
• Blurred vision and impaired mental acuity 1

Clinical pearl: Rimantadine causes fewer CNS effects than amantadine in elderly patients, but this is not the drug in question 5

Anticholinergic Effects

Monitor for atropine-like effects 1:

• Dry mouth (common adverse event) 7
• Urinary retention - notify physician if difficulty urinating occurs
• Constipation 7
• Blurred vision

Cardiovascular and Other Effects

• Orthostatic hypotension - instruct patients to rise slowly from sitting/lying 1
• Peripheral edema 7
• Falls (increased risk) 7
• Livedo reticularis (mottled skin discoloration)

Drug Interactions to Monitor

Dangerous Combinations

• CNS stimulants: Requires careful observation when co-administered 1
• Anticholinergic agents: Potentiate anticholinergic side effects - may need dose reduction of either drug 1
• Thioridazine: Worsens tremor in elderly Parkinson's patients 1
• Cationic drugs that inhibit renal tubular secretion increase amantadine levels 5:
  • Trimethoprim, triamterene
  • Possibly cimetidine and procainamide

Patient Education Points

Essential Instructions

• Avoid alcohol - increases CNS effects (dizziness, confusion, lightheadedness, orthostatic hypotension) 1
• Rise slowly from sitting or lying positions to prevent falls 1
• Do not take more than prescribed - overdose risk 1
• Report immediately: mood/mental changes, swelling of extremities, difficulty urinating, shortness of breath 1
• Seek immediate medical attention for suspected overdose 1
• Do not stop medication without physician consultation 1
• Gradually increase physical activity as Parkinson's symptoms improve 1

Melanoma Screening

• PD patients have 2-6 fold higher melanoma risk 1
• Advise regular skin examinations by dermatologist 1

Impulse Control Disorders

Screen specifically for 1:

• Intense gambling urges
• Increased sexual urges
• Uncontrolled spending
• Other compulsive behaviors

Patients may not recognize these as abnormal - nurses must ask directly. Consider dose reduction or discontinuation if these develop 1.

Dosing Administration

Standard Dosing (must adjust for renal function)

• Parkinson's disease: Start 100 mg daily, may increase to 100 mg twice daily after 1 week; maximum 400 mg/day in divided doses (requires close supervision) 1
• Influenza prophylaxis (adults <65 years): 200 mg daily or 100 mg twice daily 1
• Influenza prophylaxis (adults ≥65 years): 100 mg daily only 2, 1

Timing Considerations

• Once-daily dosing can be given as single dose 1
• If CNS effects develop with once-daily dosing, split into twice-daily schedule 1
• Extended-release formulation (ADS-5102) given once daily at bedtime 7

Special Clinical Situations

Nursing Home Residents

Research shows particularly high adverse event rates (22-41%) in elderly nursing home populations 8, 3:

• Higher risk with: assisted living residence, multiple diagnoses, CHF, elevated creatinine 8
• Standard 100 mg dose may be excessive for many residents 3
• 50 mg daily may not achieve adequate therapeutic levels 6
• Requires individualized dosing based on weight (mg/kg/day) and renal function

Traumatic Brain Injury/Disorders of Consciousness

• May be administered as IV infusion in unconscious patients for immediate CNS delivery 9
• Monitor for response using Glasgow Coma Scale and wakefulness 10
• Higher baseline GCS associated with better response 10